| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |